US Bancorp’s 89bio ETNB Stock Holding History

US Bancorp’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49	Closed	-$721	–	4084
2025 Q3	$721	Sell	49 -172	-78%	-$1.75K	﹤0.01%	3850
2025 Q2	$2.17K	Sell	221 -139	-39%	-$1.15K	﹤0.01%	3855
2025 Q1	$2.62K	Buy	360 +70	+24%	+$612	﹤0.01%	3820
2024 Q4	$2.27K	Sell	290 -82	-22%	-$675	﹤0.01%	3836
2024 Q3	$2.75K	Hold	372	–	–	﹤0.01%	3711
2024 Q2	$2.98K	Sell	372 -147	-28%	-$1.31K	﹤0.01%	3634
2024 Q1	$6.04K	Buy	519 +147	+40%	+$1.63K	﹤0.01%	3482
2023 Q4	$4.16K	Sell	372 -1,196	-76%	-$11K	﹤0.01%	3579
2023 Q3	$24.2K	Sell	1,568 -634	-29%	-$10.6K	﹤0.01%	2790
2023 Q2	$41.7K	Buy	2,202 +1,255	+133%	+$22K	﹤0.01%	2598
2023 Q1	$14.4K	Buy	947 +843	+811%	+$11K	﹤0.01%	3147
2022 Q4	$1.32K	Buy	+104	New	+$936	﹤0.01%	3875

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

US Bancorp's ETNB Position: Q4 2025 in Review

US Bancorp sold out of 89bio (ETNB) in Q4 2025, closing a stake of 49 shares — an estimated $721 sold.

US Bancorp first reported a position in ETNB in Q4 2022 and held it in 12 quarters. The position peaked at $41.7K in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

US Bancorp reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
US Bancorp sold 49 89bio shares in Q4 2025, an estimated $721.
US Bancorp first reported a position in 89bio in Q4 2022 and held it in 12 quarters.
US Bancorp's 89bio position peaked at $41.7K in Q2 2023.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on US Bancorp's 13F filing for Q4 2025, filed 30 Jan 2026.